Evaluating genomic tests from bench to bedside: a practical framework
Open Access
- 19 October 2012
- journal article
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 12 (1) , 117
Abstract
The development of genomic tests is one of the most significant technological advances in medical testing in recent decades. As these tests become increasingly available, so does the need for a pragmatic framework to evaluate the evidence base and evidence gaps in order to facilitate informed decision-making. In this article we describe such a framework that can provide a common language and benchmarks for different stakeholders of genomic testing. Each stakeholder can use this framework to specify their respective thresholds for decision-making, depending on their perspective and particular needs. This framework is applicable across a broad range of test applications and can be helpful in the application and communication of a regulatory science for genomic testing. Our framework builds upon existing work and incorporates principles familiar to researchers involved in medical testing (both diagnostic and prognostic) generally, as well as those involved in genomic testing. This framework is organized around six phases in the development of genomic tests beginning with marker identification and ending with population impact, and highlights the important knowledge gaps that need to be filled in establishing the clinical relevance of a test. Our framework focuses on the clinical appropriateness of the four main dimensions of test research questions (population/setting, intervention/index test, comparators/reference test, and outcomes) rather than prescribing a hierarchy of study designs that should be used to address each phase.Keywords
This publication has 33 references indexed in Scilit:
- Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidenceGenetics in Medicine, 2010
- The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health GenomicsPublic Health Genomics, 2010
- A standardized framework for the validation and verification of clinical molecular genetic testsEuropean Journal of Human Genetics, 2010
- Performance of Common Genetic Variants in Breast-Cancer Risk ModelsNew England Journal of Medicine, 2010
- The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancerGenetics in Medicine, 2010
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenetics in Medicine, 2009
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working GroupGenetics in Medicine, 2009
- Public Health Genomics: Translating Obesity Genomics Research Into Population Health BenefitsObesity, 2008
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Predictive genetic testing for type 2 diabetesBMJ, 2006